Edition:
United Kingdom

People: argenx SE (ARGX.BR)

ARGX.BR on Brussels Stock Exchange

125.20EUR
4:35pm BST
Change (% chg)

€0.10 (+0.08%)
Prev Close
€125.10
Open
€125.30
Day's High
€126.80
Day's Low
€124.50
Volume
105,104
Avg. Vol
94,296
52-wk High
€135.70
52-wk Low
€54.30

Van Hauwermeiren, Tim 

Mr. Tim Van Hauwermeiren serves as Chief Executive Officer, Member of the Board at argenx SE. Mr Tim Van Hauwermeiren co-founded of the company in July 15, 2008 and has served as Chief Executive Officer since July 2008. Mr. Tim has 20 years of business development and operational management experience within the biotech and consumer goods sectors. During which time he has played a key role in a number of fund raisings, IPO and the negotiation of a number of major licensing deals. Prior to becoming CEO of arGEN-X, he was senior Business Development Manager at Ablynx NV where we was part of the team that negotiated a $265 million research & development deal with Boehringer Ingelheim in 2007. Prior to joining Ablynx, Tim held various management positions with the Procter & Gamble Company in R&D and Business Development, where he conceived and developed several new products. Among those was a healthcare innovation which won the United Nations ICC World Business Award in 2004. Tim holds a Master of Science degree in Bio-engineering from the University of Gent (Belgium) and received general management training at INSEAD and The Vlerick School of Management (Executive MBA).

Basic Compensation

Total Annual Compensation, EUR 7,199,980
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 14,315
Fiscal Year Total, EUR 7,214,290

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --